French drugmaker Sanofi has made another big purchase aimed at strengthening its position in rare disease treatments, buying Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion)
from ABC News: Health http://ift.tt/2rS0eR6
via HEALTH
Aucun commentaire:
Enregistrer un commentaire